NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹973 Cr | ₹891 Cr | ₹1,004 Cr | ₹1,187 Cr | ₹1,248 Cr |
What is the latest Total Current Liabilities ratio of NECTAR LIFESCIENCES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹973 Cr |
Mar2023 | ₹891 Cr |
Mar2022 | ₹1,004 Cr |
Mar2021 | ₹1,187 Cr |
Mar2020 | ₹1,248 Cr |
How is Total Current Liabilities of NECTAR LIFESCIENCES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹973 Cr | 9.19 | |
Mar2023 | ₹891 Cr | -11.25 | |
Mar2022 | ₹1,004 Cr | -15.46 | |
Mar2021 | ₹1,187 Cr | -4.85 | |
Mar2020 | ₹1,248 Cr | - |
Compare Total Current Liabilities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹722.9 Cr | -16.4% | -19% | -4.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,744.0 Cr | -4.2% | -7.7% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,209.0 Cr | -0.6% | -5.6% | 57.5% | Stock Analytics | |
CIPLA | ₹117,762.0 Cr | 3.3% | -4.8% | 6.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,705.3 Cr | -2.4% | -12.8% | 1.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,929.3 Cr | -0.3% | -2.1% | 24.5% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | -16.4% |
-19% |
-4.4% |
SENSEX | 0.3% |
-1.8% |
8.6% |
You may also like the below Video Courses